And if it tasted sweet, that would confirm the diagnosis of diabetes
"There are several reasons someone may not take a GLP-1 consistently, including cost, inconsistent access, manufacturer shortages or loss of coverage," says Gretchen Zimmermann, M.B.A., RD, CDCES, CSOWM
The pharmacy managed to make money by selling a compounded version of semaglutide, the anti-diabetic medication that is sold under the brand names Ozempic and Wegovy, at a fraction of the cost of the FDA-approved versions of the drugs
For instance, they clearly explain whats included in monthly fees, what isnt, and how long you may need to stay on the medication
The obesity indication timeline remains less certain